Clinicn Investigator, Full Prf KFCCR Faculty, Mass General Research Institute

Professor of Medicine Harvard Medical School

Physician Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

Associate Member Broad Institute

PhD University of Pennsylvania 2003

MD University of Pennsylvania 2005

antigens; cancer immunotherapy; cellular immunology; chimerism; genetic engineering; immunotherapies; t cells Using the immune system as a cancer treatment has the potential to induce long-term, durable remissions, and perhaps even cures for some patients. The T cells of the immune system are able to specifically kill the target cells they recognize. T cells are also able to persist in the body for many years, and form immune ‘memory,’ which enables the possibility of long-term protection. The Maus laboratory is interested in using genetic engineering techniques to re-direct T cells to find and kill tumor cells while sparing healthy tissues. We aim to: develop new ways to design molecular receptors to target T cells to liquid and solid tumors; use T cells as delivery vehicles for other drugs, and use drugs to help T cells work against tumors; and understand how T cells can work as “living drugs” to treat patients with cancer.